Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded
Moffitt Ends Pilot Study Based On Duke Test, Says Action Unrelated
House DoD Report Provides $15 Million For Lung Cancer Screening
FDA Approves Votrient For Renal Cell Carcinoma
NCI Picks 11 Centers For Chemical Biology Consortium
IOM Report Says Smoking Bans Cut Heart Attack Risk
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Peter F. Garrett to people with cancer: Your story has power
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - What NHS-Galleri taught us—and what it didn’t
- The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies









